Protocol for an international prospective trial of initial therapy regimens in neutropenic patients with malignant disease.
D000380:Agranulocytosis / Q000150:complications*; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D001769:Blood / Q000382:microbiology; D002228:Carbenicillin / Q000008:administration & dosage / Q000627:therapeutic use; D002512:Cephalothin / Q000008:administration & dosage / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005839:Gentamicins / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D009369:Neoplasms / Q000150:complications*; D009503:Neutropenia / Q000150:complications*; D011446:Prospective Studies; D012107:Research Design
D005839:Gentamicins; D002228:Carbenicillin; D002512:Cephalothin